It’s make or break time for digital therapeutics We’re seeing unprecedented levels of innovation, but how much of that innovation is transforming patient lives? Our brand new DTx track, in partnership with the Digital Therapeutics Alliance (DTA), focusses on the real issues – the evolving regulatory and reimbursement essentials that will make the difference between hype and impact. Co-create with regulators:work with the EMA and national HTAs to get innovation out there Design and fund:Guidelines and frameworks to successfully design and fund your DTx clinical trials Harness patient dataand streamline all aspects of your business Scale your operationsand convince HCPs that DTx is here to stay